Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoke

Showing results (141-150 of 143) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 143 results.
Beilstein Journal of Organic Chemistry|November 19, 2025
Isoorotamide-based peptide nucleic acid nucleobases with extended linkers aimed at distal base recognition of adenosine in double helical RNAGrant D Walby, Brandon R Tessier, Tristan L Mabee, et al.
Casopis Lekaru Ceskych|June 12, 1997
[Decrease in cardiovascular disease mortality in the Czech Republic from 1984 to 1993 and its possible causes]Z Skodová, Z Písa, R Poledne, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Pageof 15

Showing results (141-150 of 143) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 143 results.
Beilstein Journal of Organic Chemistry|November 19, 2025
Isoorotamide-based peptide nucleic acid nucleobases with extended linkers aimed at distal base recognition of adenosine in double helical RNAGrant D Walby, Brandon R Tessier, Tristan L Mabee, et al.
Casopis Lekaru Ceskych|June 12, 1997
[Decrease in cardiovascular disease mortality in the Czech Republic from 1984 to 1993 and its possible causes]Z Skodová, Z Písa, R Poledne, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Pageof 15